VIVOZON Pharmaceutical’s Enafraju Q2 Sales Reach 2 Billion Won... Up 229% from Previous Quarter
Monthly Sales Surpass 1 Billion Won in June for the First Time
Expansion of Supply to Major Hospitals
Additional 120,000 Vials Ordered for Domestic Market
Preparations Underway for Phase 3 Clinical Trials in the US
VIVOZON Pharmaceutical announced on the 18th that the second-quarter sales of its non-narcotic analgesic 'Enafraju' reached approximately 2 billion won, marking a 229% increase compared to the previous quarter.
According to VIVOZON Pharmaceutical, sales of Enafraju rose from about 300 million won in April to 700 million won in May, and 1 billion won in June. In June, monthly sales surpassed 1 billion won for the first time since the product was launched in October of last year.
VIVOZON Pharmaceutical is expanding distribution, focusing on major general hospitals such as Samsung Medical Center and Shinchon Severance Hospital. The company is also widening the prescription base by expanding Drug Committee (DC) reviews to include not only general hospitals but also hospitals with fewer than 300 beds.
With the increase in sales, the company recently placed an additional order for approximately 120,000 vials. Production is being handled by its existing manufacturing partner, Huiyu Pharmaceutical of China.
The company is also promoting global commercialization. Its affiliate, VIVOZON, is expanding patents related to the high-concentration injectable formulation of Enafra, and has recently received a patent registration decision from the Eurasian Patent Office (EAPO). Preparations are underway for a Phase 3 clinical trial in the United States using this formulation, and clinical drug manufacturing for these trials has begun through a global contract manufacturer.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A representative from VIVOZON Pharmaceutical stated, "As supply is being expanded primarily to major medical institutions, sales in the second quarter more than tripled compared to the previous quarter. We will pursue solidifying our position in the domestic market and advancing global commercialization through securing additional production volume and further expanding supply to medical institutions."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.